David F. Wurtman

David F. Wurtman

Directeur/Membre du Conseil chez
GlycoMira Therapeutics, Inc.
62 ans
Health Technology
Finance
Consumer Services

Profil

David F.
Wurtman
was the founder of Lyric Pharmaceuticals, Inc., founded in 2013, where the titles held included President, Chief Executive Officer & Director from 2013 to 2018.
The current job is Director at GlycoMira Therapeutics, Inc. Former jobs include Principal at Protein Design Labs, Inc., Principal at Genzyme Corp., Vice President-International Business at ChinaBio LLC, Executive Vice President-Strategic Projects at PAVmed, Inc., Principal at EOS Biotechnology, Inc., VP-Medical Affairs & Product Development at Kineta, Inc. (Washington), and Chief Medical Officer at Lucid Diagnostics, Inc. from 2019 to 2022.
Education includes an MBA from Massachusetts Institute of Technology and a doctorate from Harvard Mit Health Sciences & Technology.

Postes actifs de David F. Wurtman

SociétésPosteDébut
Directeur/Membre du Conseil -

Anciens postes connus de David F. Wurtman

SociétésPosteFin
LUCID DIAGNOSTICS INC. Directeur Technique/Scientifique/R&D 31/03/2022
Fondateur 01/08/2018
Directeur Technique/Scientifique/R&D -
PAVMED INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de David F. Wurtman

Formation de David F. Wurtman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

3

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David F. Wurtman
🔇